The purpose of this study is to learn about how well the 20-valent pneumococcal conjugate vaccine (20vPnC) works against radiologically-confirmed community- acquired pneumonia (RAD+CAP) .
This study is seeking participants who:
are male or female ≥65 years of age.
are hospitalized with physician suspicion of community acquired pneumonia (CAP).
Participants will be asked to provide demographic and medical history information, and to provide a urine sample that will be used to test for pneumonia. We will compare how many participants have pneumonia and were previously vaccinated with 20vPnC with how many participants who have pneumonia and have not been vaccinated with 20vPnC. Participants will actively take part in the study for about 1-2 days. Information on participant's illness and hospitalization details will be collected through day 30 of their hospitalization through medical chart review.
Closest Location
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.
Condition
Pneumonia
Sex
Male or Female
Age
65+ years